Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02837315 · ClinicalTrials.gov registry record · NA

Improving Brief Marijuana Interventions With a Behavioral Economic Supplement

A NA study of Marijuana Use, sponsored by University of Memphis.

Completed
Registry status
NA
Development phase
133
Enrollment target
1
Study location

NCT02837315 is a NA study of Marijuana Use that has completed, run by University of Memphis. The registered enrollment target is 133 participants, roughly in line with the 123-participant average among 3 other Marijuana Use trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02837315, a NA study of Marijuana Use, has completed, sponsored by University of Memphis.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the efficacy of a Substance-Free Activity Session (SFAS) as a supplement to a brief motivation intervention (BMI) in reducing marijuana use and drug-related consequences in college student

Conditions Studied

Interventions

  • BEHAVIORAL Brief Motivational Intervention (BMI)
  • BEHAVIORAL Substance-Free Activity Session (SFAS)
  • BEHAVIORAL Relaxation Session

Study Locations (1)

Tennessee

  • University of Memphis - Memphis

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2014-10-23
Est. Completion 2016-11-30
Phase NA

Sponsor

University of Memphis

35 total trials

What the Registry Record Tells You About NCT02837315

The ClinicalTrials.gov registry entry for NCT02837315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 123-participant average among 3 other Marijuana Use trials with a reported enrollment target. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Marijuana Use appearing as the primary indexed condition, and to 3 interventions - of which Brief Motivational Intervention (BMI) is the first listed.

NCT02837315 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02837315 about?

NCT02837315 is a clinical study titled "Improving Brief Marijuana Interventions With a Behavioral Economic Supplement". The purpose of this study is to evaluate the efficacy of a Substance-Free Activity Session (SFAS) as a supplement to a brief motivation intervention (BMI) in reducing marijuana use and drug-related consequences in college student

What is the current status of trial NCT02837315?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2014-10-23. Estimated completion is 2016-11-30.

What conditions does trial NCT02837315 study?

This clinical trial studies the following conditions: Marijuana Use.

What interventions are being tested in trial NCT02837315?

The interventions under investigation include: Brief Motivational Intervention (BMI) (BEHAVIORAL), Substance-Free Activity Session (SFAS) (BEHAVIORAL), Relaxation Session (BEHAVIORAL).

Who is sponsoring clinical trial NCT02837315?

This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02837315 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Marijuana Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.